MedX Health Corp (MDX) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K ≈ $-497.43K USD) by net assets (CA$-10.02 Million ≈ $-7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MedX Health Corp (MDX) defensive interval to measure how many days the company can operate on defensive assets alone.

MedX Health Corp - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MedX Health Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Just Group plc
LSE:JUST
0.765x
TS Corp Preference Shares
KO:001795
0.047x
Armlogi Holding Corp. Common Stock
NASDAQ:BTOC
-0.157x
New Era Helium Inc Common Stock
NASDAQ:NEHC
0.362x
Electric Royalties Ltd
V:ELEC
-0.027x
Tae Won Mulsan
KO:001420
-0.030x
Biofrontera Inc
NASDAQ:BFRI
-0.227x
The Grob Tea Company Limited
NSE:GROBTEA
-0.064x

Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)

The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of MedX Health Corp.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-8.52 Million
≈ $-6.17 Million
CA$-2.51 Million
≈ $-1.82 Million
0.295x -38.53%
2023-12-31 CA$-7.14 Million
≈ $-5.17 Million
CA$-3.42 Million
≈ $-2.48 Million
0.479x +21.14%
2022-12-31 CA$-7.08 Million
≈ $-5.12 Million
CA$-2.80 Million
≈ $-2.03 Million
0.396x -68.21%
2021-12-31 CA$-3.63 Million
≈ $-2.63 Million
CA$-4.52 Million
≈ $-3.27 Million
1.244x -11.46%
2020-12-31 CA$-2.07 Million
≈ $-1.50 Million
CA$-2.91 Million
≈ $-2.10 Million
1.405x +204.09%
2019-12-31 CA$-2.87 Million
≈ $-2.07 Million
CA$-1.32 Million
≈ $-958.33K
0.462x -72.62%
2018-12-31 CA$-1.54 Million
≈ $-1.12 Million
CA$-2.61 Million
≈ $-1.89 Million
1.688x +72.37%
2017-12-31 CA$-1.50 Million
≈ $-1.09 Million
CA$-1.47 Million
≈ $-1.06 Million
0.979x +34.25%
2016-12-31 CA$-1.83 Million
≈ $-1.32 Million
CA$-1.33 Million
≈ $-963.12K
0.729x +225.13%
2015-12-31 CA$-2.39 Million
≈ $-1.73 Million
CA$-536.53K
≈ $-388.12K
0.224x -41.31%
2014-12-31 CA$-2.26 Million
≈ $-1.64 Million
CA$-864.08K
≈ $-625.06K
0.382x +814.58%
2013-12-31 CA$-3.40 Million
≈ $-2.46 Million
CA$-141.94K
≈ $-102.68K
0.042x --

About MedX Health Corp

V:MDX Canada Medical Devices
Market Cap
$11.86 Million
CA$16.40 Million CAD
Market Cap Rank
#26618 Global
#1096 in Canada
Share Price
CA$0.05
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.09
All Time High
CA$0.30
About

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more